Marker Therapeutics, Inc. (MRKR)
1.43
+0.02
(+1.42%)
USD |
NASDAQ |
May 21, 16:00
1.44
+0.01
(+0.70%)
After-Hours: 19:59
Marker Therapeutics Research and Development Expense (TTM) : 11.51M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Tenaya Therapeutics, Inc. | 62.37M |
| Krystal Biotech, Inc. | 54.64M |
| Neurocrine Biosciences, Inc. | 1.049B |
| Agenus, Inc. | 69.64M |
| Curis, Inc. | 26.16M |